What’s Driving Growth in the Late Stage Chronic Kidney Disease Drugs Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Late Stage Chronic Kidney Disease Drugs Market, and What Factors Will Drive It?
The late-stage chronic kidney disease drugs market has expanded rapidly in recent years. It is estimated to rise from $7.08 billion in 2024 to $7.92 billion in 2025, at a CAGR of 11.9%. Its historical growth is attributed to improved diagnostic capabilities, an aging demographic, a higher prevalence of diabetes and hypertension, increasing awareness of kidney diseases, and advancements in pharmaceutical R&D.
The late-stage chronic kidney disease drugs market is projected to expand swiftly, reaching $12.2 billion by 2029 at a CAGR of 11.4%. Growth in this sector is fueled by rising healthcare investments, increased adoption of precision medicine, advancements in regenerative medicine, a growing emphasis on patient-centric care, and global kidney disease awareness initiatives. Major trends include the expansion of regenerative therapies, increased use of telemedicine for CKD management, the development of combination treatments, early intervention strategies, and advancements in biomarker-based diagnostics.
Which Factors Are Enhancing the Growth of the late stage chronic kidney disease drugs Market?
The high prevalence of chronic kidney disease is expected to fuel the growth of the late-stage chronic kidney disease drug market. Chronic kidney diseases are conditions affecting the kidneys’ structure and function. Drugs for late-stage chronic kidney disease are used to manage blood pressure, decrease protein loss, and slow kidney damage. The Centers for Disease Control and Prevention (CDC) reported in May 2024 that about 14% of U.S. adults, or 35.5 million people, live with chronic kidney disease. As such, the prevalence of this disease is contributing to the growth of the late-stage chronic kidney disease drug market.
Explore Comprehensive Insights Into The Global Late Stage Chronic Kidney Disease Drugs Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
Who Are the Top Companies Contributing to the Growth of the Late Stage Chronic Kidney Disease Drugs Market?
Major companies operating in the late stage chronic kidney disease drugs market include:
• Pfizer Inc._x000D_
• Johnson & Johnson_x000D_
• AbbVie Inc._x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
How Are Technological Trends Affecting the Growth and Development of the Late Stage Chronic Kidney Disease Drugs Market?
Product innovation is also gaining traction in the late-stage chronic kidney disease (CKD) drug market. Companies are developing new medications to maintain their market position. For instance, in February 2022, Bayer, a Germany-based pharmaceutical company, launched Kerendia (finerenone) in India. This first-in-class non-steroidal, selective mineralocorticoid receptor antagonist is designed to treat patients with type 2 diabetes and chronic renal disease by preventing the overactivation of the mineralocorticoid receptor (MR), which is involved in the development of CKD and cardiovascular harm.
Secure Your Global Late Stage Chronic Kidney Disease Drugs Market Report Now for Fast and Efficient Delivery!
Which Growth-Oriented Segments of the Late Stage Chronic Kidney Disease Drugs Market Are Leading the Industry’s Development?
The late stage chronic kidney disease drugs market covered in this report is segmented –
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) By Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
What Are the Key Regions Powering Growth in the Late Stage Chronic Kidney Disease Drugs Market?
North America was the largest region in the late-stage chronic kidney disease drugs market in 2024. The regions covered in the late-stage chronic kidney disease drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Late Stage Chronic Kidney Disease Drugs Market Defined Across Different Regions?
Late-stage chronic kidney disease drugs refer to medicines that treat end-stage chronic kidney disease. It improves a patient’s quality of life by halting the disease’s course and avoiding or postponing the need for dialysis or a transplant.
Browse Through More Similar Reports By The Business Research Company:
Oil And Gas Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oil-and-gas-global-market-report
Oil Accumulator Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oil-accumulator-global-market-report
Oil And Gas Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oil-and-gas-pumps-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
